- Abstract:
-
Patients with the 5q- syndrome and Diamond-Blackfan anemia (DBA) suffer from a severe macrocytic anemia. The 5q- syndrome and DBA are disorders of aberrant ribosome biogenesis (ribosomopathies) and haploinsufficiency of the ribosomal protein genes RPS14 and RPS19, respectively, underlies the anemia found in these disorders. Erythroblasts obtained from patients with the 5q- syndrome and DBA show impaired mRNA translation and this defect in translation may represent a potential therapeutic targ...
Expand abstract - Journal:
- Advances in biological regulation
- Volume:
- 53
- Issue:
- 1
- Pages:
- 8-17
- Publication date:
- 2013-01-05
- DOI:
- EISSN:
-
2212-4934
- ISSN:
-
2212-4926
- URN:
-
uuid:1004059e-5714-49db-82dc-e7e74e5aa762
- Source identifiers:
-
354107
- Local pid:
- pubs:354107
- Language:
- English
- Keywords:
- Copyright date:
- 2013
Journal article
Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record